| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/12/1995 | EP0647234A1 Steroidal glycosides for treating hypercholesterolemia |
| 04/12/1995 | EP0647222A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 04/12/1995 | EP0647137A1 Glycine receptor antagonists and the use thereof |
| 04/12/1995 | EP0568546B1 Bridged cyclic ketal derivatives |
| 04/12/1995 | EP0539509B1 4-alkylimidazole derivatives |
| 04/12/1995 | EP0487520B1 Compressed powder medicaments |
| 04/12/1995 | CN1101349A Novel compounds |
| 04/12/1995 | CN1101260A Material for adjusting function of biology |
| 04/12/1995 | CN1028169C Process for direct isolation of captopril |
| 04/11/1995 | US5405988 9-substituted bicyclo[3.3.0]octane derivatives, process for their production and their pharmaceutical use |
| 04/11/1995 | US5405964 Imidazopyridines |
| 04/11/1995 | US5405874 Improving short term memory by administering spin-trapping agents such as N-tert-butyl-alpha-phenylnitrone, 5,5-dimethyl-1-pyrroline N-oxide or alpha-/4-pyridyl 1-oxide/-N-tert-butylnitrone |
| 04/11/1995 | US5405872 Anti-hypertensive tetralins |
| 04/11/1995 | US5405849 Treating hypertension, congestive heart failure |
| 04/11/1995 | US5405847 4,5-dihydro-4-oxo-pyrrolo[1,2-a]quinoxalinones and corresponding aza analogs and a process for their preparation |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/09/1995 | CA2133804A1 1,2-dihydro-2-oxo-3-methylsulfonylaminomethylpyridines |
| 04/08/1995 | CA2132770A1 Aryl and heterocyclic cyanoguanidine derivatives |
| 04/08/1995 | CA2132766A1 4-arylamino-benzopyran and related compounds |
| 04/06/1995 | WO1995009188A1 Antithrombotic |
| 04/06/1995 | WO1995009186A1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas |
| 04/06/1995 | WO1995009010A1 Arteriosclerosis remedy |
| 04/06/1995 | WO1994028895A3 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 04/06/1995 | CA2172978A1 Arteriosclerosis remedy |
| 04/05/1995 | EP0646132A1 Amino sugars, glycoproteins, method of preparing them, medicines containing them and their use |
| 04/05/1995 | EP0646131A1 Serum amyloid a protein |
| 04/05/1995 | EP0646112A1 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 04/05/1995 | EP0646005A1 Methods for treating arteriosclerosis |
| 04/05/1995 | EP0365664B1 Use of synthetic l-carnitine in food for domestic dogs or cats |
| 04/05/1995 | EP0180615B1 Novel atrial natriuretic/vasodilator polypeptides |
| 04/05/1995 | CN1101047A Intermediates useful in the preparation of pyranyl cyanoguanidine derivatives and methods of preparing same |
| 04/05/1995 | CN1101039A 哌嗪衍生物 Piperazine derivatives |
| 04/05/1995 | CN1028099C W-phenoxy-heterocyclic compounds |
| 04/04/1995 | US5403933 Indolizine derivatives, with pharmaceutical activity |
| 04/04/1995 | US5403921 Drinking a solution of glycerol and water two hours before exertion and continuing until one-half hour before starting; phsiological effects |
| 04/04/1995 | US5403856 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/04/1995 | US5403854 Substituted N-heteroaryl -1,2-diaminocyclobutene-3,4-diones |
| 04/04/1995 | US5403853 Substituted N-aryl-1,2-diaminocyclobutene-3,4-diones |
| 04/04/1995 | US5403849 4-heterocyclophenyl-substituted dihydropyridines |
| 04/04/1995 | US5403840 Inclusion complexes of N-ethoxycarbonyl 1-3-morpholino-sydnonimine or salts formed with cyclodextrin-derivatives, preparation thereof and pharmaceutical compositions containing the same |
| 04/04/1995 | US5403834 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 04/04/1995 | US5403827 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them |
| 04/04/1995 | US5403731 Reacting the enzyme with a 1,1'-carbonyldimidazole-modified water-soluble polyoxyalkylene glycol |
| 04/04/1995 | CA2046910C Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents |
| 04/04/1995 | CA1335104C Diphenyl-3-azahexane and diphenyl-4-azaheptane derivatives, pharmaceutical compositions containing them and process for their preparation |
| 04/04/1995 | CA1335102C P-hydroxy phenone derivatives and drugs containing these |
| 04/04/1995 | CA1335077C Process for the manufacture of apolipoproteins from human blood plasma or serum |
| 04/04/1995 | CA1335075C Method of inhibiting platelet dependent arterial thrombosis |
| 03/30/1995 | WO1995008630A1 Surface loop structural analogues of fibroblast growth factors |
| 03/30/1995 | WO1995008559A1 Novel urethane-containing aminosteroid compounds |
| 03/30/1995 | WO1995008558A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 03/30/1995 | WO1995008557A1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 03/30/1995 | WO1995008532A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 03/30/1995 | WO1995008528A1 Triaryl-ethylene derivatives for use in therapy |
| 03/30/1995 | WO1995008343A1 Modified truncated complement system regulators |
| 03/30/1995 | WO1995003822A3 Use of relaxin as therapeutic or preventing agent |
| 03/30/1995 | CA2182530A1 Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry |
| 03/30/1995 | CA2172497A1 Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| 03/30/1995 | CA2172495A1 Novel urethane-containing aminosteroid compounds |
| 03/29/1995 | EP0645376A1 Substituted 1-phenyl-oxazolidin-2-one derivatives, their preparation and their use as adhesion-receptor antagonists |
| 03/29/1995 | EP0645375A1 Use of benzene-sulfonyl-indole derivatives for the preparation of a medicament |
| 03/29/1995 | EP0644897A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors |
| 03/29/1995 | EP0644895A1 Active component of parathyroid hypertensive factor |
| 03/29/1995 | EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase |
| 03/29/1995 | EP0644891A1 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 03/29/1995 | EP0644885A1 Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 03/29/1995 | EP0644877A1 Substituted-hexahydrobenzo a]phenanthridines |
| 03/29/1995 | EP0644756A1 System for controlled release of antiarrhythmic agents |
| 03/29/1995 | CN1100725A 2-amino-4-heteroaryl-1,4-dihydropyridines, processes for their preparation and their use in medicaments |
| 03/29/1995 | CN1100721A Imidazopyridine |
| 03/29/1995 | CN1028024C Method for preparation of tetrazole excitatory amino acid receptor antagonists |
| 03/28/1995 | US5401875 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments |
| 03/28/1995 | US5401851 Preparation of proline derivatives |
| 03/28/1995 | US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof |
| 03/28/1995 | US5401762 Aminoalkyl-substituted thiazolin-2-ones, the preparation and use thereof |
| 03/28/1995 | US5401758 For treating ischemia |
| 03/28/1995 | US5401753 Substituted n-heteroaryl-1, 2-diaminocyclobutene-3, 3-diones |
| 03/28/1995 | US5401743 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles the preparation and use thereof |
| 03/28/1995 | US5401738 Benzimidazole compounds |
| 03/28/1995 | US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia |
| 03/28/1995 | US5401498 Pharmaceuticals comprising polyhydroxymethylene derivatives, process for their preparation and use |
| 03/28/1995 | CA2029785C Glutaric acid derivatives and preparations thereof |
| 03/28/1995 | CA1334967C Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same |
| 03/28/1995 | CA1334936C Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| 03/24/1995 | CA2132579A1 Adhesion receptor antagonists iii |
| 03/23/1995 | WO1995007903A1 Heterocyclic carboxamide derivatives with antiarrhythmic activity |
| 03/23/1995 | WO1995007899A1 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxide-3-carboxylic acid derivatives, their preparation and drugs containing same |
| 03/23/1995 | WO1995007885A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 03/23/1995 | WO1995007711A1 Therapeutic treatment for inhibiting blood vessel blockage using a polypeptide |
| 03/23/1995 | WO1995007697A2 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 03/23/1995 | WO1995007694A1 Use of thiazolidinediones to prevent or delay onset of niddm |
| 03/23/1995 | WO1995005393A3 Lipopolysaccharide-binding and neutralizing peptides |
| 03/23/1995 | WO1995004142A3 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 03/23/1995 | CA2170619A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 03/23/1995 | CA2168751A1 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| 03/22/1995 | EP0643780A1 Multiple solvent cleaning system. |
| 03/22/1995 | EP0643709A1 4-(1-$i(H)-PYRROL-1-YL)IMIDAZOLES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY |
| 03/22/1995 | EP0643686A1 New compounds |
| 03/22/1995 | EP0643585A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis |
| 03/22/1995 | EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy |